Context-dependent Transcriptional Cooperation Mediated by Cardiac Transcription Factors Csx/Nkx-2.5 and GATA-4*

Ichiro ShiojimaDagger , Issei Komuro§, Toru Oka, Yukio Hiroi, Takehiko Mizuno, Eiki Takimoto, Koshiro Monzen, Ryuichi Aikawa, Hiroshi Akazawa, Tsutomu Yamazaki, Sumiyo Kudoh, and Yoshio Yazaki

From the Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
REFERENCES

Although the cardiac homeobox gene Csx/Nkx-2.5 is essential for normal heart development, little is known about its regulatory mechanisms. In a search for the downstream target genes of Csx/Nkx-2.5, we found that the atrial natriuretic peptide (ANP) gene promoter was strongly transactivated by Csx/Nkx-2.5. Deletion and mutational analyses of the ANP promoter revealed that the Csx/Nkx-2.5-binding element (NKE2) located at -240 was required for high level transactivation by Csx/Nkx-2.5. We also found that Csx/Nkx-2.5 and GATA-4 displayed synergistic transcriptional activation of the ANP promoter, and in contrast to previous reports (Durocher, D., Charron, F., Warren, R., Schwartz, R. J., and Nemer, M. (1997) EMBO J. 16, 5687-5696; Lee, Y., Shioi, T., Kasahara, H., Jobe, S. M., Wiese, R. J., Markham, B., and Izumo, S (1998) Mol. Cell. Biol. 18, 3120-3129), this synergism was dependent on binding of Csx/Nkx-2.5 to NKE2, but not on GATA-4-DNA interactions. Although GATA-4 also potentiated the Csx/Nkx-2.5-induced transactivation of the artificial promoter that contains multimerized Csx/Nkx-2.5-binding sites, Csx/Nkx-2.5 reduced the GATA-4-induced transactivation of the GATA-4-dependent promoters. These findings indicate that the cooperative transcriptional regulation mediated by Csx/Nkx-2.5 and GATA-4 is promoter context-dependent and suggest that the complex cis-trans interactions may fine-tune gene expression in cardiac myocytes.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
REFERENCES

Murine Csx/Nkx-2.5 is a homeobox-containing gene originally identified as a potential vertebrate homolog of the Drosophila gene tinman (1, 2). tinman is expressed in all mesodermal cells during germ-band elongation, but its expression is subsequently restricted to the dorsal cardiac mesoderm and, in the later developmental stage, to the dorsal vessel, an insect equivalent of the vertebrate heart (3). A loss-of-function mutant of the Drosophila tinman gene exhibits complete loss of heart formation, indicating that tinman is essential for Drosophila heart formation (4, 5). The expression of Csx/Nkx-2.5 is also highly restricted to the heart and the heart progenitor cells from the very early developmental stage when the two heart primordia are symmetrically situated in the anterior lateral mesoderm (1, 2), and targeted disruption of murine Csx/Nkx-2.5 results in embryonic lethality due to the abnormal looping morphogenesis of the primary heart tube (6). Furthermore, Csx/Nkx-2.5 family genes are also identified in various vertebrate species from zebrafish to humans (7-10). These results indicate that Csx/Nkx-2.5 is also essential for normal heart development and morphogenesis in vertebrates like the tinman gene in Drosophila and suggest that the regulatory mechanism of heart development controlled by Csx/Nkx-2.5 is highly conserved in evolution.

To clarify the molecular framework of vertebrate cardiogenesis, the identification of upstream regulatory factors that control the expression of the Csx/Nkx-2.5 gene and the downstream targets of the Csx/Nkx-2.5 protein is necessary (11-13). In Drosophila, tinman gene expression is controlled by several upstream factors including twist, decapentaplegic, and wingless (3, 14-16), and tinman directly regulates the expression of D-MEF2 via the cardiac enhancer in the D-MEF2 gene (17). In vertebrates, however, there is only limited information regarding the upstream factors or the downstream targets of Csx/Nkx-2.5. Among the possible regulatory factors of cardiac development, bone morphogenetic proteins have recently been identified as potential inducing signals of Csx/Nkx-2.5 that are secreted from the endoderm (18). As for the downstream targets of Csx/Nkx-2.5, the expression of ventricular myosin light chain 2, CARP (cardiac ankyrin-repeat protein), and a basic helix-loop-helix transcription factor (eHAND) is significantly reduced in Csx/Nkx-2.5 knockout mice (6, 19, 20), suggesting that Csx/Nkx-2.5 may, either directly or indirectly, regulate the expression of these genes. In addition, since CARP promoter activity is down-regulated by the overexpression of the dominant-negative form of Csx/Nkx-2.5 in cultured cardiac myocytes (19), CARP may be a direct target of Csx/Nkx-2.5, although the precise cis-regulatory sequences in the CARP promoter are not known.

In addition to Csx/Nkx-2.5, several transcription factors have also been identified as potential regulators of cardiac development. Among these molecules, MEF2C and GATA-4 are thought to be involved in the early step of cardiac development because both of these factors appear in the precardiac mesoderm almost simultaneously with Csx/Nkx-2.5 and earlier than any other known transcription factors implicated in cardiogenesis (21, 22). MEF2C belongs to the MEF2 (myocyte enhancer factor-2) subfamily of MADS box transcription factors and binds to the AT-rich element in the regulatory regions of numerous muscle-specific genes (23). GATA-4 is a member of the cardiac GATA subfamily, which is composed of GATA-4/5/6 and binds to the WGATAR motif in the promoter regions of cardiac- or gut-specific genes (24). Targeted disruption of MEF2C results in embryonic lethal phenotype due to the right ventricular dysplasia (25), and GATA-4-/- mice are also embryonic lethal because of the failure of the fusion of cardiac primordia at the midline due to the ventral folding/fusion defect of the developing embryo (26, 27). All these results indicate that Csx/Nkx-2.5, MEF2C, and GATA-4 are essential transcription factors required for normal heart development and suggest that multiple transcription factors coordinately regulate the process of cardiogenesis.

In this study, to clarify the genetic pathways that control vertebrate heart development, we tried to find the direct downstream target genes of Csx/Nkx-2.5. Cotransfection of the expression plasmid of human Csx/Nkx-2.5 and the reporter genes with promoters of various cardiac-specific genes linked to the firefly luciferase gene revealed that the atrial natriuretic peptide (ANP)1 gene promoter is strongly transactivated by Csx/Nkx-2.5 via the high affinity Csx/Nkx-2.5-binding element termed NKE2 (Nkx-2.5 response element-2) located at -250 in the 5'-flanking region of the rat ANP gene. Because the GATA motif is located near NKE2, we cotransfected the expression plasmids of Csx/Nkx-2.5 and GATA-4 simultaneously with the 300-bp ANP promoter-containing reporter gene and found that the ANP promoter is synergistically transactivated by these two factors. Deletion and mutational analyses indicated that this synergism is dependent on NKE2, but not on the two GATA sites within this proximal promoter. The artificial promoter construct containing multimerized Csx/Nkx-2.5-binding sequences was also synergistically transactivated by Csx/Nkx-2.5 and GATA-4. However, Csx/Nkx-2.5 and GATA-4 negatively cooperated on the promoters that are dependent on GATA-4. Co-immunoprecipitation experiments and glutathione S-transferase (GST) pull-down assay demonstrated that Csx/Nkx-2.5 and GATA-4 interact with each other both in vivo and in vitro, and electrophoretic mobility shift assay revealed that the DNA-binding affinity of GATA-4 was reduced in the presence of Csx/Nkx-2.5, whereas that of Csx/Nkx-2.5 was not affected by GATA-4. Our present results indicate that the Csx/Nkx-2.5-GATA-4 synergism is differentially regulated depending on the context of the cis-elements with which the two factors interact and suggest that the complex interactions among transcription factors and target DNAs fine-tune gene expression in cardiac myocytes and regulate development of the heart.

    MATERIALS AND METHODS

Construction of Plasmids-- The expression plasmid of human Csx/Nkx-2.5 (pEFSA-CSX1) and that of human GATA-4 (pSSRa-hGATA4) were previously described (10, 28). To construct luciferase reporter genes for deletion analysis, various length of ANP genomic fragments were amplified by polymerase chain reaction (PCR) with primers containing a SacI site in the forward primer and an XhoI site in the reverse primer. For mutational analyses, two GATA elements (located at -120 and -270) and one Csx/Nkx-2.5-binding element (NKE2, located at -250) within the ANP(300)-luc construct containing the 300-bp 5'-flanking region of the ANP gene were mutated either alone or in combination. To introduce mutations into NKE2 and/or the GATA element at -270, forward primers that contained corresponding mutations were used for PCR. A two-step PCR method was used to introduce mutations into the GATA element at -120. PCR products were digested with SacI and XhoI; subcloned into the SacI/XhoI site of PGV-B (TOYO INKI), a promoter-less vector containing the luciferase gene; and verified by sequencing. The 4x(TTF-1)-tk-luc reporter gene (which contains four tandem copies of Csx/Nkx-2.5-binding elements), the 6x(GATA)-tk-luc reporter gene (which contains six tandem copies of GATA-4-binding elements), and a reporter gene containing the proximal 400 bp of the human IL-5 gene promoter were previously described (10, 28).

Cell Culture, DNA Transfection, and Reporter Gene Assay-- COS-7 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Transient transfections were performed 24 h after plating with the standard calcium phosphate method. For each 35-mm dish, the reporter construct, expression vectors of CSX1 and/or GATA-4, SV40-beta gal as an internal control, and the appropriate amounts of parental expression plasmid were transfected with the total amount of DNA kept constant at 2.5 µg. Luciferase activities were measured 48 h after transfection with a Berthold Lumat LB9501 luminometer, and differences in transfection efficiency were corrected relative to the level of beta -galactosidase activity. Experiments were repeated at least three times in triplicate, and representative data are shown.

In Vitro Transcription and Translation-- PCR-amplified cDNA fragments corresponding to the coding region of CSX1 derivatives and GATA-4 derivatives were subcloned into pSPUTK vector (Promega) containing the SP6 RNA polymerase promoter and the sequence of the Xenopus beta -globin 5'-untranslated region. Proteins were transcribed and translated in vitro using the TNT SP6 coupled reticulocyte lysate system (Promega) with or without the [35S]methionine.

Electrophoretic Mobility Shift Assay (EMSA)-- Double-stranded oligonucleotides corresponding to the TTF-1 (thyroid transcription factor-1)-binding sequence, NKE, NKE2, and the GATA site with or without mutations were synthesized with GATC overhanging at the 5' terminus of each oligonucleotide. The two complementary oligonucleotides were annealed and labeled with [alpha -32P]dCTP using Klenow enzyme. Labeled probes were incubated with 5 µl of programmed or unprogrammed reticulocyte lysate and 2 µg of poly(dI-dC) in 20 µl of binding buffer (10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 10% glycerol, 0.5 mM dithiothreitol, and 0.05% Nonidet P-40) for 30 min at room temperature. The protein/DNA mixture was resolved on 5% polyacrylamide gel in 0.5× Tris borate/EDTA buffer at 4 °C for 2 h at 150 V.

Co-immunoprecipitation Experiments-- The expression plasmid of HA-tagged CSX1 (pEFSA-HA-CSX1) was described previously (10). To generate the expression plasmid of Myc-tagged GATA-4 (pBK-CMVMyc-GATA4), the corresponding cDNA fragment was amplified by PCR and subcloned into the XbaI/ClaI site of modified pBK-CMV vector (Stratagene), which contains the Myc tag sequence at the NheI/XbaI site. These constructs were transiently transfected into COS-7 cells by the calcium phosphate method, and 48 h after transfection, nuclear extracts were prepared as described previously (10). Nuclear extracts were then incubated with anti-HA monoclonal antibody 12CA5 in NTEN binding buffer (150 mM NaCl, 50 mM Tris (pH 7.5), 0.5 mM EDTA, 0.5% Nonidet P-40, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, and 0.25% bovine serum albumin) for 2 h at 4 °C with gentle rotation, and the immune complex was precipitated with protein A-Sepharose beads, washed three times with NTEN binding buffer, resuspended in sample buffer, and subjected to SDS-PAGE. Resolved proteins were transferred onto Hybond ECL nitrocellulose membrane (Amersham Pharmacia Biotech) and immunoblotted with anti-Myc polyclonal antibody. Horseradish peroxidase-conjugated anti-rabbit IgG was used as the secondary antibody, and the immune complex was visualized using the ECL detection kit (Amersham Pharmacia Biotech).

GST Fusion Protein-- PCR-amplified cDNA fragments corresponding to full-length CSX1 and CSX1 derivatives were subcloned in frame into the BamHI/EcoRI site of pGEX-2T (Amersham Pharmacia Biotech). To express GST fusion proteins in bacteria, JM109 cells were transformed with pGEX-2T-CSX1 constructs, and fusion protein expression was induced by 0.1 mM isopropyl-beta -D-thiogalactopyranoside for 5 h at 25 °C. Cells were harvested, resuspended in phosphate-buffered saline containing 1% Triton X-100, sonicated, and centrifuged. GST fusion proteins were purified by binding to glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech) according to the manufacturer's directions. The concentrations and purity of the glutathione-bound GST-CSX1 proteins were estimated by SDS-PAGE and Coomassie Blue staining.

GST Pull-down Assay-- In vitro interaction assays were performed with GST-CSX1 fusion proteins and in vitro translated GATA-4 derivatives. GST or GST-CSX1 fusion proteins immobilized on glutathione-Sepharose 4B beads and in vitro translated GATA-4 derivatives labeled with [35S]methionine were mixed in NTEN binding buffer, incubated for 2 h at 4 °C with gentle rotation, and washed three times with binding buffer. Beads were resuspended in SDS-PAGE sample buffer, and GATA-4 derivatives bound to GST-CSX1 fusion proteins were resolved by SDS-PAGE and visualized by fluorography.

    RESULTS

Csx/Nkx-2.5 Transactivates the ANP Promoter-- To search for the direct downstream target genes of the Csx/Nkx-2.5 protein, we cotransfected luciferase reporter constructs containing various cardiac-specific gene promoters and the Csx/Nkx-2.5 expression vector into COS-7 cells and examined whether the transcriptional activation of native promoters was observed by the overexpression of Csx/Nkx-2.5. Among the reporter constructs tested, Csx/Nkx-2.5 most strongly transactivated the ANP-luc reporter containing the 600-bp 5'-flanking region of the rat ANP gene (Fig. 1), suggesting that the ANP gene is a downstream target of Csx/Nkx-2.5.


View larger version (49K):
[in this window]
[in a new window]
 
Fig. 1.   Csx/Nkx-2.5 transactivates the ANP proximal promoter. COS-7 cells were transiently transfected with the luciferase reporter construct (0.2 µg/3.5-cm dish) containing the 600-bp 5'-flanking region of the rat ANP gene and the indicated increasing amounts of the CSX1 expression plasmid. Overexpression of CSX1 transactivated the ANP promoter in a dose-dependent manner.

The Csx/Nkx-2.5-binding Site (NKE2) Located at -250 Is Required for High Level Transactivation of the ANP Promoter by Csx/Nkx-2.5-- To identify the cis-regulatory elements in the ANP promoter that mediate the transcriptional activation by Csx/Nkx-2.5, luciferase reporter constructs containing various lengths of the ANP promoter region were cotransfected with the Csx/Nkx-2.5 expression vector. Deletion of the ANP 5'-flanking region from -600 to -390 did not significantly change the -fold activation of the ANP promoter by Csx/Nkx-2.5. However, deletion between -390 and -160 markedly reduced the -fold induction of the promoter activity, although further deletion up to -125 had little effect (Fig. 2A), indicating that the Csx/Nkx-2.5-responsive element is situated between -390 and -160 of the ANP 5'-flanking region.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   The Csx/Nkx-2.5-binding element (NKE2) located at -250 is a developmentally conserved high affinity binding sequence for Csx/Nkx-2.5 and mediates high level transactivation of the ANP promoter by Csx/Nkx-2.5. A, deletion analysis of the ANP promoter. Luciferase reporter constructs (0.2 µg/3.5-cm dish) containing various lengths of the ANP promoter were cotransfected into COS-7 cells with an equal amount of CSX1 expression plasmid. Deletion of the promoter region between -390 and -160 significantly decreased the -fold activation of the ANP promoter activity by CSX1, and this region contains the consensus Csx/Nkx-2.5-binding element (NKE2), as shown. B, deletion and mutational analyses of NKE2. The luciferase reporter constructs (0.2 µg/3.5-cm dish) shown (left) were transfected with the CSX1 expression plasmid. The deletion or mutation of NKE2 decreased the -fold induction of the ANP promoter activity by CSX1. EMSA with in vitro translated CSX1 protein demonstrated that NKE2 is a high affinity binding element of the Csx/Nkx-2.5 protein, and mutations introduced into NKE2 dramatically decreased the binding affinity of NKE2. C, binding affinity of NKE and NKE2 for the Csx/Nkx-2.5 protein. The sequence comparison of NKE2 with different species indicated that this element is identical for the rat, mouse, and human ANP promoters (right). EMSA with in vitro translated CSX1 protein revealed that NKE2 has a much higher binding affinity for the Csx/Nkx-2.5 protein than NKE. wt, wild-type; mt, mutant.

Because the consensus Csx/Nkx-2.5-binding element (TGAAGTG) was located at -250 in the ANP promoter, we speculated that this Csx/Nkx-2.5-binding element might mediate the transcriptional activation of the ANP promoter by the Csx/Nkx-2.5 protein. To examine this possibility, the deletion and mutant constructs shown in Fig. 2B were cotransfected with the expression vector of Csx/Nkx-2.5. Deletion or mutation of the Csx/Nkx-2.5-binding element located at -250 in the ANP promoter markedly reduced the -fold induction of transactivation by Csx/Nkx-2.5, whereas deletion up to -270 of the ANP promoter, which did not affect the Csx/Nkx-2.5-binding element, had little effect on the transactivation by Csx/Nkx-2.5 (Fig. 2B). Because previous reports have shown that Csx/Nkx-2.5 binds to another Nkx-2.5-responsive element called NKE located at -80 of the ANP promoter, we designated the Csx/Nkx-2.5-binding element located at -250 as NKE2. Our present data suggest that NKE2 is required for high level transactivation of the ANP promoter by Csx/Nkx-2.5.

NKE2 Is a High Affinity Binding Site for Csx/Nkx-2.5 and Is Highly Conserved in Evolution-- To examine whether Csx/Nkx-2.5 binds to NKE2, EMSA was performed with in vitro translated Csx/Nkx-2.5 protein and oligonucleotide probes corresponding to the TTF-1-binding element, wild-type NKE2, mutant NKE2, and wild-type NKE. Under our experimental conditions, the Csx/Nkx-2.5 protein bound to NKE2 with almost equal binding affinity compared with the TTF-1-binding element, although it bound to NKE with much lower binding affinity and did not bind to mutant NKE2 (Fig. 2, B, right; and C, right). Comparison of the sequences of the human, mouse, and rat ANP promoters revealed that NKE2 is highly conserved in these species (Fig. 2C, left). Together, these results strongly suggest that NKE2, as well as proximal NKE, plays a critical role in the transcriptional regulation of the ANP gene by Csx/Nkx-2.5.

Csx/Nkx-2.5 and GATA-4 Synergistically Transactivate the ANP Promoter-- Because the GATA site was located at -280 just distal from NKE2, we examined whether Csx/Nkx-2.5 and GATA-4 cooperatively regulate the transcription of the ANP gene. When the ANP(300)-luc construct containing the 300-bp 5'-flanking region of the ANP promoter was cotransfected with the Csx/Nkx-2.5 expression plasmid alone, modest transactivation of the ANP promoter was observed. When ANP(300)-luc was cotransfected with the GATA-4 expression plasmid alone, no significant increase in the promoter activity was observed, suggesting that GATA-4 is a weak transactivator of the ANP promoter under our assay conditions. However, overexpression of both GATA-4 and Csx/Nkx-2.5 induced much stronger activity of the ANP promoter than that induced by the expression of Csx/Nkx-2.5 alone (Fig. 3A, left), suggesting that Csx/Nkx-2.5 and GATA-4 synergistically transactivate the ANP promoter.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3.   Csx/Nkx-2.5 and GATA-4 synergistically transactivate the ANP promoter, and NKE2 is required for the Csx/Nkx-2.5-GATA-4 synergism. A, analysis of the effect of deletions in the ANP promoter on Csx/Nkx-2.5-GATA-4 synergism. The luciferase reporter constructs (0.2 µg/3.5-cm dish) containing the 300-, 270-, and 240-bp 5'-flanking regions of the ANP promoter were cotransfected with the expression plasmids of CSX1 and/or GATA-4 (0.2 µg each/3.5-cm dish). Deletion of NKE2 diminished the synergy between Csx/Nkx-2.5 and GATA-4 (right), whereas deletion of the GATA site alone had no effect on Csx/Nkx-2.5-GATA-4 synergism (middle). B, analysis of the effect of mutations of NKE2 and the two GATA sites in the ANP proximal promoter on Csx/Nkx-2.5-GATA-4 synergism. Mutations were introduced into the two GATA sites and NKE2 either alone or in combination, and the resultant eight reporter constructs (wild-type (wt) and mutants 1-7 (m1-m7); 0.2 µg/3.5-cm dish) were cotransfected with the expression plasmids of CSX1 and/or GATA-4 (0.2 µg each/3.5-cm dish). The results obtained could be divided into two cases, positive for synergism as observed with the reporter construct containing the 300-bp ANP promoter (A, left) or negative for synergism as observed with the reporter construct containing the 240-bp ANP promoter (A, right), and are therefore shown on the right as + and -, respectively.

Csx/Nkx-2.5-binding Sites, but Not GATA Sites, Are Required for Csx/Nkx-2.5-GATA-4 Positive Cooperation-- The apparent cooperativity of Csx/Nkx-2.5 and GATA-4 was further investigated using deletion and mutant constructs of the ANP promoter. Removal of the region between -300 and -270 of the ANP promoter, which resulted in the deletion of the GATA site at -280, had little effect on the Csx/Nkx-2.5-GATA-4 synergism as well as Csx/Nkx-2.5-induced activation (Fig. 3A, middle). However, deletion of the promoter region between -270 and -240, in which NKE2 is located, abolished not only Csx/Nkx-2.5-induced activation of the ANP promoter, but also the cooperativity between Csx/Nkx-2.5 and GATA-4 (Fig. 3A, right), suggesting that NKE2, but not the GATA site at -280, is required for the Csx/Nkx-2.5-GATA-4 transcriptional synergism. To test whether NKE2 (but not GATA elements) is important for the Csx/Nkx-2.5-GATA-4 synergism, mutations were introduced into NKE2 and/or two GATA sites within the ANP(300)-luc construct either alone or in combination, and the effects of coexpression of Csx/Nkx-2.5 and GATA-4 on these reporter genes were examined. Cotransfection of the expression plasmids of Csx/Nkx-2.5 and GATA-4 with wild-type or mutant ANP(300)-luc constructs revealed that NKE2, but not the two GATA sites, was required for the synergistic transactivation of the ANP promoter by the two factors (Fig. 3B). For example, even when the two GATA sites were mutated, Csx/Nkx-2.5-GATA-4 synergism was still observed if NKE2 remained intact (Fig. 3B, ANP(300-m5-)-luc), whereas Csx/Nkx-2.5-GATA-4 synergism was abolished by the mutation of NKE2 irrespective of the presence or absence of the intact GATA sites (ANP(300-m2-)-luc, ANP(300-m3-)-luc, ANP(300-m6-)-luc, and ANP(300-m7-)-luc).

The dependence of Csx/Nkx-2.5-GATA-4 transcriptional synergism on the Csx/Nkx-2.5-binding site was also investigated with the artificial reporter construct containing multimerized Csx/Nkx-2.5-binding sites (4x(TTF-1)-tk-luc). Cotransfection experiments revealed that 4x(TTF-1)-tk-luc is synergistically transactivated by Csx/Nkx-2.5 and GATA-4 (Fig. 4). All these results collectively suggest that the Csx/Nkx-2.5-binding site is essential, but that the GATA-4-binding site is dispensable, for the transcriptional synergy between Csx/Nkx-2.5 and GATA-4.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 4.   Csx/Nkx-2.5 and GATA-4 synergistically transactivate the Csx/Nkx-2.5-dependent promoters. COS-7 cells were cotransfected with the luciferase reporter construct (0.6 µg/3.5-cm dish) containing multimerized Csx/Nkx-2.5-binding sites (4x(TTF-1)-tk-luc) and the expression plasmids of CSX1 and/or GATA-4 (0.2 µg each/3.5-cm dish). Csx/Nkx-2.5 and GATA-4 synergistically transactivated the reporter construct, whereas GATA-4 alone had little effect.

Csx/Nkx-2.5 and GATA-4 Exhibit Negative Cooperation on GATA-4-dependent Promoters-- To further investigate the Csx/Nkx-2.5-GATA-4 transcriptional cooperation, we examined the effects of the coexpression of Csx/Nkx-2.5 and GATA-4 on GATA-4-dependent promoters. For this purpose, we utilized the artificial promoter that contains multimerized GATA sites (6x(GATA)-tk-luc) and the IL-5 promoter that has been shown to be positively regulated by GATA-4 and does not contain the putative Csx/Nkx-2.5-binding sequence in the proximal promoter region. As expected, when GATA-4 was cotransfected with the 6x(GATA)-tk-luc reporter gene, modest transcriptional activation was observed, whereas Csx/Nkx-2.5 did not affect the activity of the reporter gene. Unexpectedly, however, cotransfection of Csx/Nkx-2.5 with GATA-4 partially inhibited the GATA-4-induced transactivation of the reporter gene (Fig. 5, left). Essentially the same results were obtained when the IL-5 promoter-containing reporter gene was examined (Fig. 5, right). These results suggest that the transcriptional cooperation between Csx/Nkx-2.5 and GATA-4 is promoter context-dependent; these two factors exhibit positive cooperation on Csx/Nkx-2.5-dependent promoters and negative cooperation on GATA-4-dependent promoters.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5.   Csx/Nkx-2.5 and GATA-4 exhibit negative cooperation on GATA-4-dependent promoters. COS-7 cells were cotransfected with the luciferase reporter construct (0.6 µg/3.5-cm dish) containing multimerized GATA sites (left) or the 400-bp proximal promoter region of the human IL-5 gene (right) and the expression plasmids of CSX1 and/or GATA-4 (0.2 µg each/3.5-cm dish). In both cases, coexpression of CSX1 with GATA-4 reduced the -fold activation of the reporter gene induced by GATA-4 alone, indicating that there exists negative cooperation between Csx/Nkx-2.5 and GATA-4 on GATA-4-dependent promoters.

Csx/Nkx-2.5 and GATA-4 Interact with Each Other Both in Vivo and in Vitro-- To examine whether Csx/Nkx-2.5 and GATA-4 directly interact with each other in vivo, co-immunoprecipitation experiments were performed. COS-7 cells were transiently transfected with HA-tagged Csx/Nkx-2.5 and Myc-tagged GATA-4, and nuclear extracts were immunoprecipitated with anti-HA antibody, followed by immunoblotting with anti-Myc antibody. Western blot analysis revealed that Myc-GATA-4 protein was co-immunoprecipitated with HA-Csx/Nkx-2.5 (Fig. 6A), indicating the interaction of HA-Csx/Nkx-2.5 and Myc-GATA-4 in vivo, either direct or indirect.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 6.   Csx/Nkx-2.5 and GATA-4 interact with each other. A, co-immunoprecipitation. COS-7 cells were transiently transfected with the expression plasmids of HA-tagged CSX1 and Myc-tagged GATA-4. Nuclear extracts were prepared, immunoprecipitated (IP) with anti-HA antibody, subjected to SDS-PAGE, and immunoblotted with anti-Myc antibody. The arrow indicates the co-immunoprecipitated GATA-4 protein. B, GST pull-down assay. In vitro translated GATA-4 protein labeled with 35S was incubated with GST alone or GST-CSX1 immobilized on glutathione-Sepharose beads, and bound proteins were analyzed by SDS-PAGE and fluorography. The arrow indicates the GATA-4 protein. C, schematic illustration of GST-CSX1 derivatives and GATA-4 derivatives used in the GST pull-down assay. GST-CSX(HD) interacted with GATA-4(ZF), indicating that CSX1 and GATA-4 interact with each other via the homeodomain of CSX1 and the zinc-finger domain of GATA-4.

To further confirm the direct interaction of these two factors, GST pull-down assay was performed with GST-Csx/Nkx-2.5 derivatives and in vitro translated GATA-4 derivatives. Full-length GST-Csx/Nkx-2.5 immobilized on glutathione-Sepharose beads could retain in vitro translated GATA-4, whereas GST protein could not bind to GATA-4, indicating that Csx/Nkx-2.5 directly interacts with GATA-4 in vitro (Fig. 6B). Examination of the binding of GATA-4 derivatives to full-length GST-Csx/Nkx-2.5 revealed that the zinc-finger domain of GATA-4 (GATA-4(ZF)) is sufficient for interacting with Csx/Nkx-2.5. Since GATA-4(ZF) bound to GST-Csx/Nkx-2.5(HD), the homeodomain of Csx/Nkx-2.5 is sufficient for interacting with GATA-4 (Fig. 6C).

Csx/Nkx-2.5 Reduces the DNA-binding Affinity of GATA-4-- To determine the mechanism of positive and negative cooperation of Csx/Nkx-2.5 and GATA-4 on Csx/Nkx-2.5- and GATA-4-dependent promoters, respectively, the DNA-binding activities of Csx/Nkx-2.5 and GATA-4 were examined in the presence or absence of each other. EMSA revealed that the DNA-binding activity of Csx/Nkx-2.5 was not affected by GATA-4 (Fig. 7, left), whereas that of GATA-4 was reduced when the Csx/Nkx-2.5 protein coexisted (right). These results suggest that the negative cooperation of Csx/Nkx-2.5 and GATA-4 on GATA-4-dependent promoters is at least in part due to the reduced DNA-binding affinity of GATA-4 in the presence of Csx/Nkx-2.5, whereas the positive cooperation of Csx/Nkx-2.5 and GATA-4 on Csx/Nkx-2.5-dependent promoters is not due to the cooperative binding of these factors to DNA.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 7.   Csx/Nkx-2.5 reduces the DNA-binding affinity of GATA-4. EMSA was performed with in vitro translated CSX1 protein and GATA-4 protein. When NKE2 was used as a probe, the binding affinity of the CSX1 protein was not affected by the presence of the GATA-4 protein in the reaction mixture (left). On the other hand, when the GATA element was used as a probe, the binding affinity of the GATA-4 protein for the GATA element was reduced by the presence of the CSX1 protein (right). NS represents the nonspecific binding of the GATA probe to the protein contained in the reticulocyte lysate.


    DISCUSSION

In this study, we have obtained the following results. (i) The ANP promoter is strongly transactivated by Csx/Nkx-2.5. (ii) High level transactivation of the ANP promoter by Csx/Nkx-2.5 is dependent on NKE2, a Csx/Nkx-2.5-binding element located at -250. (iii) NKE2 is a high affinity binding site for Csx/Nkx-2.5 and is highly conserved in evolution. (iv) Csx/Nkx-2.5 and GATA-4 synergistically transactivate the ANP promoter. (v) Cooperative transcriptional activation of the ANP promoter by Csx/Nkx-2.5 and GATA-4 is mediated by NKE2, but is independent of GATA-4-DNA interaction. (vi) Cooperative transactivation by Csx/Nkx-2.5 and GATA-4 is also observed on the artificial promoter containing multimerized Csx/Nkx-2.5-binding sites. (vii) Csx/Nkx-2.5 and GATA-4 exhibit negative cooperation on the GATA-4-dependent promoters such as the human IL-5 gene or the artificial promoter containing multimerized GATA sites. (viii) Csx/Nkx-2.5 and GATA-4 directly interact with each other both in vivo and in vitro, and the homeodomain of Csx/Nkx-2.5 and the zinc-finger domain of GATA-4 are required for the interaction. (viii) Csx/Nkx-2.5 reduces the DNA-binding affinity of GATA-4.

The ANP Promoter Is Transactivated by Csx/Nkx-2.5 via Multiple cis-Elements-- Our initial objective in this study was to identify the direct downstream targets of Csx/Nkx-2.5 in the genetic pathway of heart formation. Among the various cardiac-specific promoters tested, ANP was strongly transactivated by Csx/Nkx-2.5, and high level transactivation of the ANP promoter by Csx/Nkx-2.5 was mediated by NKE2, the Csx/Nkx-2.5-binding site located at -250 in the rat ANP promoter. Recently, other investigators have shown that Csx/Nkx-2.5 transactivates the ANP promoter via NKE, the proximal Csx/Nkx-2.5-binding element located at -80 (29). Consistent with their results, modest transcriptional activation of the ANP promoter by Csx/Nkx-2.5 was observed when NKE2 was deleted or mutated. Together, these results suggest that the activity of the ANP promoter is regulated by Csx/Nkx-2.5 via multiple cis-elements.

ANP is one of the few genes whose promoter has been identified to have Csx/Nkx-2.5-binding elements and to be transactivated by Csx/Nkx-2.5. In addition, endogenous ANP mRNA is increased in the hearts of human Csx/Nkx-2.5-overexpressing mice recently generated in our laboratory,2 strongly suggesting that ANP is a direct target gene of Csx/Nkx-2.5 in vivo. In Drosophila, D-MEF2 is the only known direct target of tinman (17). D-MEF2 expression in cardiac cells is positively regulated by tinman, and the transactivation of D-MEF2 by tinman is mediated via the two tinman-binding elements in the cardiac enhancer located in the 5'-flanking region of the D-MEF2 gene. The tinman-binding elements in the D-MEF2 enhancer and NKE2 completely match the consensus high affinity binding sequence for Csx/Nkx-2.5, TNAAGTG (30), whereas two Csx/Nkx-2.5-binding sites in NKE do not (29). Our EMSA analysis also showed that the binding affinity of NKE2 is much higher than that of NKE. These results suggest that NKE2 is a critical cis-regulatory element in the induction and activation of ANP gene.

Csx/Nkx-2.5 and GATA-4 Synergistically Transactivate the ANP Promoter-- The existence of the GATA site near NKE2 prompted us to examine the possible cooperative action of Csx/Nkx-2.5 and GATA-4. Although GATA-4 was a relatively weak transactivator of the ANP promoter under our experimental conditions, the simultaneous overexpression of GATA-4 with Csx/Nkx-2.5 markedly potentiated the Csx/Nkx-2.5-induced transactivation of the ANP promoter, indicating that there exists a positive cooperation between these two factors. While this manuscript was in preparation, Durocher et al. (29) reported that Csx/Nkx-2.5 could cooperate with GATA-4 to activate transcription of the ANP promoter. Our results are essentially similar to theirs, but they differ in two respects. (i) They used a reporter construct containing the 130-bp 5'-flanking region of the rat ANP promoter and observed the cooperative transcriptional activation by Csx/Nkx-2.5 and GATA-4, whereas we could not detect such synergism when NKE2 at -250 was deleted or mutated; and (ii) they showed that DNA binding of the two factors is required for synergistic transcriptional activation, whereas we could detect the cooperative action even when GATA-4 sites were deleted or mutated. Although the reasons for such discrepancies are unclear at present, they may be due to the differences in the cell types or the reporter and effector constructs used in the transfection experiments.

Csx/Nkx-2.5 and GATA-4 Synergistically Transactivate Csx/Nkx-2.5-dependent Promoters-- The finding that the positive cooperation of Csx/Nkx-2.5 and GATA-4 on the ANP promoter was independent of GATA-4-DNA interaction prompted us to examine the effects of coexpression of these two factors on the Csx/Nkx-2.5-dependent artificial promoter, 4x(TTF-1)-tk-luc. Cotransfection experiments revealed that Csx/Nkx-2.5 and GATA-4 also exhibited positive cooperation on this promoter, although GATA-4 alone induced no significant increase in the promoter activity. Essentially the same results were recently reported by Sepulveda et al. (31) regarding the cardiac alpha -actin promoter, which has no functional GATA elements and is not significantly activated by overexpression of GATA-4. These results suggest that the Csx/Nkx-2.5-GATA-4 synergism depends on Csx/Nkx-2.5-DNA interaction and Csx/Nkx-2.5-GATA-4 association, but not on GATA-4-DNA interaction.

Context-dependent Transcriptional Cooperation of Csx/Nkx-2.5 and GATA-4: Csx/Nkx-2.5 and GATA-4 Exhibit Negative Cooperation on GATA-4-dependent Promoters-- If the direct protein-protein interaction of Csx/Nkx-2.5 and GATA-4 mediates the transcriptional synergy, one might expect that these two factors also exhibit positive transcriptional cooperation on GATA-4-dependent promoters. Unexpectedly, however, Csx/Nkx-2.5 and GATA-4 displayed negative cooperation on both the artificial and native promoters that are positively regulated by GATA-4, but not by Csx/Nkx-2.5. Together with the findings on the ANP promoter and the 4x(TTF-1)-tk-luc reporter gene, these results suggest that the Csx/Nkx-2.5-GATA-4 transcriptional cooperation depends on the context of the promoter; their cooperation is positive when the promoter contains Csx/Nkx-2.5-binding sites irrespective of the presence or absence of GATA sites and negative when the promoter contains only GATA sites.

Csx/Nkx-2.5 and GATA-4 Directly Interact with Each Other-- GST pull-down assay and co-immunoprecipitation experiments demonstrated that Csx/Nkx-2.5 and GATA-4 directly interact with each other both in vivo and in vitro via the homeodomain of Csx/Nkx-2.5 and the zinc-finger domain of GATA-4, which is consistent with recent reports (31, 32). Several transcription factors have been shown to associate with Csx/Nkx-2.5, and the domains of the Csx/Nkx-2.5 protein required for the association are different depending on the interacting partner. For example, the serum response factor (SRF) associates with Csx/Nkx-2.5 via the MADS box of SRF and the homeodomain of Csx/Nkx-2.5 and synergistically transactivates the cardiac alpha -actin gene promoter, and this cooperative action of SRF and Csx/Nkx-2.5 requires SRF-DNA interaction, but is independent of Csx/Nkx-2.5-DNA interaction (33). Our previous study (10) suggested that the N-terminal domain of human Csx/Nkx-2.5 interacts with other nuclear factor(s) and mediates the transactivation activity without directly binding to DNA. Furthermore, we have recently isolated a multiple zinc finger-containing putative transcription factor that interacts with the N-terminal domain and the homeodomain of Csx/Nkx-2.5 using a yeast two-hybrid interaction screen.3 Taken together, these results suggest that the transcriptional regulation by Csx/Nkx-2.5 may be controlled by multiple protein-protein interactions mediated by distinct interaction domains of Csx/Nkx-2.5.

Possible Mechanisms for Csx/Nkx-2.5-GATA-4 Negative Cooperation on GATA-4-dependent Promoters: Csx/Nkx-2.5 Reduces the DNA-binding Affinity of GATA-4-- In our EMSA analysis with in vitro translated GATA-4 and Csx/Nkx-2.5, we detected a reduced DNA-binding affinity of GATA-4 in the presence of Csx/Nkx-2.5. Sepulveda et al. (31) recently reported that GATA-4 slightly increased the DNA-binding affinity of Csx/Nkx-2.5. However, we could not detect such an increase in the DNA-binding affinity of Csx/Nkx-2.5 in the presence of GATA-4, although Csx/Nkx-2.5 and GATA-4 might affect each other's DNA-binding affinity in an in vivo situation. Our results suggest that the negative cooperation of Csx/Nkx-2.5 and GATA-4 on GATA-4-dependent promoters is at least in part due to the decrease in the DNA-binding affinity of GATA-4 in the presence of Csx/Nkx-2.5.

Possible Mechanisms for Csx/Nkx-2.5-GATA-4 Positive Cooperation on Csx/Nkx-2.5-dependent Promoters-- One general mechanism for positive transcriptional synergy is the cooperative binding of activators to DNA. For example, the homeodomain protein Phox directly binds to SRF and increases the DNA-binding affinity of SRF (34). Likewise, Drosophila extradenticle associates with Ultrabithorax and raises the DNA-binding affinity of the extradenticle-Ultrabithorax protein complex (35-37), and so is the case with the vertebrate Pbx and Hox products (38). In these cases, direct contact between two factors increases their binding affinity for DNA, which can be detected by EMSA analysis. However, in our experiments, the degree of the cooperative binding of Csx/Nkx-2.5 to its target site in the presence of GATA-4 seems to be relatively small and does not seem to fully explain the positive cooperation observed in this study.

In another model of transcriptional synergy, the interaction between two factors induces a conformational change in one of the factors and enables it to efficiently activate transcription. Two recent reports suggest that GATA-4 relieves the autorepression of Csx/Nkx-2.5 by the C-terminal inhibitory domain (29, 31). The interaction of GATA-4 with Csx/Nkx-2.5 enhances the transcriptional activity of Csx/Nkx-2.5 by displacing the C-terminal inhibitory domain, and therefore, C-terminally truncated Csx/Nkx-2.5 does not exhibit synergy with GATA-4. However, in our hands, the Csx/Nkx-2.5-GATA-4 transcriptional synergy on NKE2 or on multimerized Csx/Nkx-2.5 sites was still observed when the C-terminally deleted form of Csx/Nkx-2.5 was used instead of wild-type Csx/Nkx-2.5 (data not shown), suggesting that there exist multiple modes of cooperative transactivation mediated by Csx/Nkx-2.5 and GATA-4.

An alternative model is that Csx/Nkx-2.5 and GATA-4 create a specific protein complex that interacts with the basal transcriptional machinery more efficiently than the individual factors. In this case, the "efficient" interaction with the basal transcription complex may result from simultaneous interactions with different binding sites between the Csx/Nkx-2.5-GATA-4 protein complex and the basal transcription complex and/or from the stabilization of the basal transcription complex by the specific assembly of the multiprotein complex. Further studies are necessary to determine the mechanism of positive synergistic action mediated by Csx/Nkx-2.5 and GATA-4.

Context-dependent Transcriptional Cooperation Mediated by Csx/Nkx-2.5 and GATA-4-- Accumulating evidence suggests that multiple cis-trans interactions between sequence-specific transcription factors and factor-binding sites in the enhancer as well as the protein-protein interactions among transcription factors and cofactors regulate gene transcription during development or in response to external stimuli. Furthermore, in some natural enhancers, changes in the relative positions or orientations of protein-binding sites within the enhancer lead to the inactivation of the enhancer activity (39), and some transcription factors act as activators in one promoter and as repressors in other promoters (40). Our present results suggest that synergistic action between two transcription factors also depends on the promoter context (Fig. 8) and that such transcriptional regulatory mechanisms fine-tune gene expression in cardiac myocytes and regulate the process of heart development.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 8.   Several modes of transcriptional cooperativity between Csx/Nkx-2.5 and GATA-4. A, when the promoter contains both NKE and GATA elements, Csx/Nkx-2.5 and GATA-4 exhibit positive transcriptional cooperation. In this case, the interaction between GATA-4 and DNA may be either direct or indirect. B, when the promoter contains only NKE elements, Csx/Nkx-2.5 and GATA-4 also exhibit positive transcriptional cooperation. In this case, the interaction between GATA-4 and DNA is indirect and possibly mediated by the protein-protein interaction between Csx/Nkx-2.5 and GATA-4. C, when the promoter contains only GATA elements, Csx/Nkx-2.5 and GATA-4 exhibit negative transcriptional cooperation. Coexistence of Csx/Nkx-2.5 and GATA-4 reduces the GATA-4-induced promoter activity, possibly due to the reduced DNA-binding affinity of GATA-4 in the presence of Csx/Nkx-2.5.


    ACKNOWLEDGEMENTS

We thank Chika Masuo and Kaoru Kuwabara for technical assistance and Hisamaru Hirai and Tetsuya Yamagata for plasmids.

    FOOTNOTES

* This work was supported in part by grants from the Japanese Ministry of Education, Science, and Culture; the Japan Heart Foundation; Yamanouchi Pharmaceuticals; and Tanabe Medical Frontier Conference.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Supported by the Sankyo Foundation of Life Science.

§ To whom correspondence should be addressed. Tel.: 81-3-3815-5411; Fax: 81-3-3818-6673; E-mail: komuro-tky{at}umin.ac.jp.

2 E. Takimoto, I. Komuro, I. Shiojima, and T. Mizuno, unpublished observations.

3 Y. Hiroi, S. Kudoh, I. Shiojima, and I. Komuro, unpublished observations.

    ABBREVIATIONS

The abbreviations used are: ANP, atrial natriuretic peptide; bp, base pair(s); IL-5, interleukin-5; GST, glutathione S-transferase; PCR, polymerase chain reaction; EMSA, electrophoretic mobility shift assay; HA, hemagglutinin; PAGE, polyacrylamide gel electrophoresis; SRF, serum response factor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
REFERENCES
  1. Komuro, I., and Izumo, S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8145-8149[Abstract/Free Full Text]
  2. Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., and Harvey, R. P. (1993) Development (Camb.) 119, 419-431[Abstract/Free Full Text]
  3. Bodmer, R., Jan, L. Y., and Jan, Y. N. (1990) Development (Camb.) 110, 661-669[Abstract]
  4. Azpiazu, N., and Frasch, M. (1993) Genes Dev. 7, 1325-1340[Abstract]
  5. Bodmer, R. (1993) Development (Camb.) 118, 719-729[Abstract/Free Full Text]
  6. Lyons, I., Parsons, L. M., Hartley, L., Li, R., Andrews, J. E., Robb, L., and Harvey, R. P (1995) Genes Dev. 9, 1654-1666[Abstract]
  7. Tonissen, K. F., Drysdale, T. A., Lints, T. J., Harvey, R. P., and Kreig, P. A. (1993) Dev. Biol. 162, 325-328[CrossRef]
  8. Schultheiss, T. M., Xydas, S., and Lassar, A. B. (1995) Development (Camb.) 121, 4203-4214[Abstract/Free Full Text]
  9. Chen, J. N., and Fishman, M. C. (1996) Development (Camb.) 122, 3809-3816[Abstract/Free Full Text]
  10. Shiojima, I., Komuro, I., Mizuno, T., Aikawa, R., Akazawa, H., Oka, T., Yamazaki, T., and Yazaki, Y. (1996) Circ. Res. 79, 920-929[Abstract/Free Full Text]
  11. Bodmer, R. (1995) Trends. Cardiovasc. Med. 5, 21-28[CrossRef]
  12. Olson, E. N., and Srivastava, D. (1996) Science 272, 671-676[Abstract]
  13. Harvey, R. P. (1996) Dev. Biol. 178, 203-216[CrossRef][Medline] [Order article via Infotrieve]
  14. Wu, X., Golden, K., and Bodmer, R. (1995) Dev. Biol. 169, 619-628[CrossRef][Medline] [Order article via Infotrieve]
  15. Staehling-Hampton, K., Hoffmann, F. M., Baylies, M. K., Rushton, E., and Bate, M. (1994) Nature 372, 783-786[Medline] [Order article via Infotrieve]
  16. Frasch, M. (1995) Nature 374, 464-467[CrossRef][Medline] [Order article via Infotrieve]
  17. Gajewski, K., Kim, Y., Lee, Y. M., Olson, E. N., and Schulz, R. A. (1997) EMBO J. 16, 515-522[Abstract/Free Full Text]
  18. Schultheiss, T. M., Burch, J. B. E., and Lassar, A. B. (1997) Genes Dev. 11, 451-462[Abstract]
  19. Zou, Y., Evans, S., Chen, J., Kuo, H. C., Harvey, R. P., and Chien, K. R. (1997) Development (Camb.) 124, 793-804[Abstract/Free Full Text]
  20. Biben, C., and Harvey, R. P. (1997) Genes Dev. 11, 1357-1369[Abstract]
  21. Edmondson, D. G., Lyons, G. E., Martin, J. M., and Olson, E. N. (1994) Development (Camb.) 120, 1251-1263[Abstract/Free Full Text]
  22. Heikinheimo, M., Scandrett, J. M., and Wilson, D. B. (1994) Dev. Biol. 164, 361-373[CrossRef][Medline] [Order article via Infotrieve]
  23. Olson, E. N., Perry, M., and Schulz, R. A. (1995) Dev. Biol. 172, 2-14[CrossRef][Medline] [Order article via Infotrieve]
  24. Evans, T. (1997) Trends Cardiovasc. Med. 7, 75-83[CrossRef]
  25. Lin, Q., Schwarz, J., Bucana, C., and Olson, E. N. (1997) Science 276, 1404-1407[Abstract/Free Full Text]
  26. Kuo, C. T., Morrisey, E. E., Anandappa, R., Sigrist, K., Lu, M. M., Parmacek, M. S., Soudais, C., and Leiden, J. M. (1997) Genes Dev. 11, 1048-1060[Abstract]
  27. Molkentin, J. D., Lin, Q., Duncan, S. A., and Olson, E. N. (1997) Genes Dev. 11, 1061-1072[Abstract]
  28. Yamagata, T., Nishida, J., Sakai, R., Tanaka, T., Honda, H., Hirano, N., Mano, H., Yazaki, Y., and Hirai, H. (1995) Mol. Cell. Biol. 15, 3830-3839[Abstract]
  29. Durocher, D., Charron, F., Warren, R., Schwartz, R. J., and Nemer, M. (1997) EMBO J. 16, 5687-5696[Abstract/Free Full Text]
  30. Chen, C. Y., and Schwartz, R. J. (1995) J. Biol. Chem. 270, 15628-15633[Abstract/Free Full Text]
  31. Sepulveda, J. L., Belaguli, N., Nigam, V., Chen, C. Y., Nemer, M., and Schwartz, R. J. (1998) Mol. Cell. Biol 18, 3405-3415[Abstract/Free Full Text]
  32. Lee, Y., Shioi, T., Kasahara, H., Jobe, S. M., Wiese, R. J., Markham, B., and Izumo, S (1998) Mol. Cell. Biol 18, 3120-3129[Abstract/Free Full Text]
  33. Chen, C. Y., and Schwartz, R., J. (1996) Mol. Cell. Biol. 16, 6372-6384[Abstract]
  34. Grueneberg, D. A., Natesan, S., Alexandre, C., and Gilman, M. Z. (1992) Science 257, 1089-1095[Medline] [Order article via Infotrieve]
  35. Chan, S. K., Jaffe, L., Capovilla, M., Botas, J., and Mann, R. S. (1994) Cell 78, 603-615[Medline] [Order article via Infotrieve]
  36. van Dijk, M. A., and Murre, C. (1994) Cell 78, 617-624[Medline] [Order article via Infotrieve]
  37. Rauskolb, C., and Wieschaus, E. (1994) EMBO J. 13, 3561-3569[Abstract]
  38. Lu, Q., Knoephler, P. S., Scheele, J., Wright, D. D., and Kamps, M. P. (1995) Mol. Cell. Biol. 15, 3786-3795[Abstract]
  39. Giese, K., Cox, J., and Grosscheld, R. (1992) Cell 69, 185-196[Medline] [Order article via Infotrieve]
  40. Natesan, S., and Gilman, M. Z. (1993) Genes Dev. 7, 2497-2509[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.